» Articles » PMID: 16488379

Non-motor Symptoms of Parkinson's Disease: Diagnosis and Management

Overview
Journal Lancet Neurol
Specialty Neurology
Date 2006 Feb 21
PMID 16488379
Citations 875
Authors
Affiliations
Soon will be listed here.
Abstract

The clinical diagnosis of Parkinson's disease rests on the identification of the characteristics related to dopamine deficiency that are a consequence of degeneration of the substantia nigra pars compacta. However, non-dopaminergic and non-motor symptoms are sometimes present before diagnosis and almost inevitably emerge with disease progression. Indeed, non-motor symptoms dominate the clinical picture of advanced Parkinson's disease and contribute to severe disability, impaired quality of life, and shortened life expectancy. By contrast with the dopaminergic symptoms of the disease, for which treatment is available, non-motor symptoms are often poorly recognised and inadequately treated. However, attention is now being focused on the recognition and quantitation of non-motor symptoms, which will form the basis of improved treatments. Some non-motor symptoms, including depression, constipation, pain, genitourinary problems, and sleep disorders, can be improved with available treatments. Other non-motor symptoms can be more refractory and need the introduction of novel non-dopaminergic drugs. Inevitably, the development of treatments that can slow or prevent the progression of Parkinson's disease and its multicentric neurodegeneration provides the best hope of curing non-motor symptoms.

Citing Articles

Contribution of fatigue experienced by Parkinson's Disease patients on caregiver burden.

Landolfo S, Urso D, Santoro C, Batzu L, Gnoni V, Giugno A J Neurol. 2025; 272(4):264.

PMID: 40072620 DOI: 10.1007/s00415-025-12962-z.


Low doses of cannabis extract ameliorate non-motor symptoms of Parkinson's disease patients: a case series.

Ruver-Martins A, Martinez I, Holla V, de Souza B, da Silva E, Novoa D Front Hum Neurosci. 2025; 18:1466438.

PMID: 40066073 PMC: 11891160. DOI: 10.3389/fnhum.2024.1466438.


The role of on cognitive impairment in Parkinson's disease and Parkinsonisms.

Rosal A, Martin S, Strafella A Front Neurosci. 2025; 19:1515374.

PMID: 40052092 PMC: 11882537. DOI: 10.3389/fnins.2025.1515374.


SVHRSP protects against rotenone-induced neurodegeneration in mice by inhibiting TLR4/NF-κB-mediated neuroinflammation via gut microbiota.

Chen M, Zhang Y, Hou L, Zhao Z, Tang P, Sun Q NPJ Parkinsons Dis. 2025; 11(1):43.

PMID: 40050294 PMC: 11885645. DOI: 10.1038/s41531-025-00892-6.


Effect of Vestibular-Oriented Balance Training on Postural Control and Risk of Fall in Patients With Parkinson's Disease.

Khallaf M, Jaber H, Alameri M, Magdy D, Kamal H, Hassanin M Neurol Res Int. 2025; 2025:6846267.

PMID: 40041239 PMC: 11879567. DOI: 10.1155/nri/6846267.